Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996-2004

Journal of Rheumatology

Volumn 36, Issue 1, 2009, Pages 63-67

  Ward, Michael M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Endstage renal disease; Incidence; Lupus nephritis; Systemic lupus erythematosus

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COLOMBIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; GROUPS BY AGE; HUMAN; INCIDENCE; INFORMATION PROCESSING; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; POPULATION; PRIORITY JOURNAL; RACE; RENAL REPLACEMENT THERAPY; RISK FACTOR; SEX RATIO; SOCIAL STATUS; UNITED STATES;

EID: 58149502461     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080625     Document Type: Article

References (14)

1. Tugwell P, de Savigny D, Hawker G, Robinson V. Applying clinical epidemiological methods to health equity: the equity-effectiveness loop. BMJ 2006;332:358-61.
2. Ward MM. Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995. Arch Intern Med 2000;160:3136-40.
3. United States Renal Data System. USRDS 2005 annual data report: Atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2005.
4. Ward MM. Socioeconomic status and the incidence of ESRD. Am J Kidney Dis 2008;51:563-72.
5. U.S. Census Bureau Population Estimates. Internet. Available from: http://www.census.gov/popest/datasets.html. Accessed Aug 28 2008.
6. Missouri Census Data Center. Internet. Available from: http://mcdc2.missouri.edu/webrepts/geography/zip.resources.html#profiles
7. Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 2006;295:1912-20.
8. Jha AK, Li Z, Orav EJ, Epstein AM. Care in U.S. hospitals - The Hospital Quality Alliance Program. N Engl J Med 2005;353:265-74.
9. Cunningham WE, Markson LE, Andersen RM, et al. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States. HCSUS Consortium. J Acquir Immune Defic Syndr 2000;25:115-23.
10. Winston CA, Wortley PM, Lees KA. Factors associated with vaccination of Medicare beneficiaries in five U.S. communities: Results from the Racial and Ethnic Adult Disparities in Immunization Initiative survey. J Am Geriat Soc 2006;54:303-10.
11. Jayne D. Current management of lupus nephritis: popular misconceptions. Lupus 2007;16:217-20.
12. Fiehn C, Hajjar Y, Mueller K, Waldherr R, Ho AD, Andrassy K. Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Ann Rheum Dis 2003;62:435-9.
13. Faurschou M, Starklint H, Halberg P, Jacobsen S. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol 2006;33:1563-9.
14. Bruce IN, Gladman DD, Urowitz MB. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: the role of patient nonadherence. Arthritis Care Res 2000;13:406-8.